Streptococcus pneumoniae and influenza vaccination rates in oncological patients — data from Germany
Despite strong recommendations to vaccinate and the clear clinical need to prevent infections in the vulnerable group of oncological patients, only the minority was vaccinated against Streptococcus pneumoniae or influenza, underlining the urgent need for better vaccination strategies in this high-risk population.
Authors
- Maike de Wit (ORCID: https://orcid.org/0000-0001-5222-7133)
- Mark Reinwald (ORCID: https://orcid.org/0000-0002-6506-2136)
- Til R. Kiderlen (ORCID: https://orcid.org/0000-0003-3158-9527)
- Werner Dammermann (ORCID: https://orcid.org/0000-0001-6847-3769)
- Jonathan Underwood (ORCID: https://orcid.org/0000-0001-6963-2821)
- Sandra Schwarzlose-Schwarck
- P. Markus Deckert (ORCID: https://orcid.org/0000-0001-9569-5607)
- Emma Niederstein
Institutions
- Auguste-Viktoria-Klinik (DE)
- Vivantes Klinikum (DE)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Universitätsklinikum Brandenburg an der Havel (DE)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1007/s00520-024-09023-y
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer